A Study to Describe the Breast Cancer Patient Population, Treatment, and Results in Indian Patients Receiving Combinations of the Medicines Called Palbociclib for Advanced Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Breast Carcinoma|Breast Neoplasms|Breast Tumors|Cancer of Breast
Interventions: DRUG: Palbociclib plus hormonal treatment - first line treatment|DRUG: Palbociclib plus hormonal treatment - second line treatment
Sponsor: Pfizer